37275754|t|Malaysian brown macroalga Padina australis mitigates lipopolysaccharide-stimulated neuroinflammation in BV2 microglial cells.
37275754|a|Objectives: Neuroinflammation and microglial activation are pathological features in central nervous system disorders. Excess levels of reactive oxygen species (ROS) and pro-inflammatory cytokines have been implicated in exacerbation of neuronal damage during chronic activation of microglial cells. Padina australis, a brown macroalga, has been demonstrated to have various pharmacological properties such as anti-neuroinflammatory activity. However, the underlying mechanism mediating the anti-neuroinflammatory potential of P. australis remains poorly understood. We explored the use of Malaysian P. australis in attenuating lipopolysaccharide (LPS)-stimulated neuroinflammation in BV2 microglial cells. Materials and Methods: Fresh specimens of P. australis were freeze-dried and subjected to ethanol extraction. The ethanol extract (PAEE) was evaluated for its protective effects against 1 microg/ml LPS-stimulated neuroinflammation in BV2 microglial cells. Results: LPS reduced the viability of BV2 microglia cells and increased the levels of nitric oxide (NO), prostaglandin E2 (PGE2), intracellular reactive oxygen species (ROS), inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6). However, the neuroinflammatory response was reversed by 0.5-2.0 mg/ml PAEE in a dose-dependent manner. Analysis of liquid chromatography-mass spectrometry (LC-MS) of PAEE subfractions revealed five compounds; methyl alpha-eleostearate, ethyl alpha-eleostearate, niacinamide, stearamide, and linoleic acid. Conclusion: The protective effects of PAEE against LPS-stimulated neuroinflammation in BV2 microglial cells were found to be mediated by the suppression of excess levels of intracellular ROS and pro-inflammatory mediators and cytokines, denoting the protective role of P. australis in combating continuous neuroinflammation. Our findings support the use of P. australis as a possible therapeutic for neuroinflammatory and neurodegenerative diseases.
37275754	16	25	macroalga	Chemical	-
37275754	26	42	Padina australis	Species	200424
37275754	53	71	lipopolysaccharide	Chemical	MESH:D008070
37275754	83	100	neuroinflammation	Disease	MESH:D000090862
37275754	104	107	BV2	CellLine	CVCL:0182
37275754	138	155	Neuroinflammation	Disease	MESH:D000090862
37275754	211	243	central nervous system disorders	Disease	MESH:D002493
37275754	262	285	reactive oxygen species	Chemical	MESH:D017382
37275754	287	290	ROS	Chemical	MESH:D017382
37275754	300	312	inflammatory	Disease	MESH:D007249
37275754	363	378	neuronal damage	Disease	MESH:D009410
37275754	426	442	Padina australis	Species	200424
37275754	541	558	neuroinflammatory	Disease	MESH:D000090862
37275754	622	639	neuroinflammatory	Disease	MESH:D000090862
37275754	653	665	P. australis	Species	29695;56345;256038;1396451;2506474
37275754	726	738	P. australis	Species	29695;56345;256038;1396451;2506474
37275754	754	772	lipopolysaccharide	Chemical	MESH:D008070
37275754	774	777	LPS	Chemical	MESH:D008070
37275754	790	807	neuroinflammation	Disease	MESH:D000090862
37275754	811	814	BV2	CellLine	CVCL:0182
37275754	875	887	P. australis	Species	29695;56345;256038;1396451;2506474
37275754	923	930	ethanol	Chemical	MESH:D000431
37275754	947	962	ethanol extract	Chemical	-
37275754	964	968	PAEE	Chemical	-
37275754	1031	1034	LPS	Chemical	MESH:D008070
37275754	1046	1063	neuroinflammation	Disease	MESH:D000090862
37275754	1067	1070	BV2	CellLine	CVCL:0182
37275754	1098	1101	LPS	Chemical	MESH:D008070
37275754	1127	1130	BV2	CellLine	CVCL:0182
37275754	1175	1187	nitric oxide	Chemical	MESH:D009569
37275754	1194	1210	prostaglandin E2	Chemical	MESH:D015232
37275754	1212	1216	PGE2	Chemical	MESH:D015232
37275754	1233	1256	reactive oxygen species	Chemical	MESH:D017382
37275754	1258	1261	ROS	Chemical	MESH:D017382
37275754	1264	1295	inducible nitric oxide synthase	Gene	18126
37275754	1297	1301	iNOS	Gene	18126
37275754	1304	1320	cyclooxygenase-2	Gene	19225
37275754	1322	1327	COX-2	Gene	19225
37275754	1330	1357	tumor necrosis factor-alpha	Gene	21926
37275754	1359	1368	TNF-alpha	Gene	21926
37275754	1375	1388	interleukin-6	Gene	16193
37275754	1390	1394	IL-6	Gene	16193
37275754	1410	1427	neuroinflammatory	Disease	MESH:D000090862
37275754	1467	1471	PAEE	Chemical	-
37275754	1563	1567	PAEE	Chemical	-
37275754	1606	1631	methyl alpha-eleostearate	Chemical	-
37275754	1633	1657	ethyl alpha-eleostearate	Chemical	-
37275754	1659	1670	niacinamide	Chemical	MESH:D009536
37275754	1672	1682	stearamide	Chemical	-
37275754	1688	1701	linoleic acid	Chemical	MESH:D019787
37275754	1741	1745	PAEE	Chemical	-
37275754	1754	1757	LPS	Chemical	MESH:D008070
37275754	1769	1786	neuroinflammation	Disease	MESH:D000090862
37275754	1790	1793	BV2	CellLine	CVCL:0182
37275754	1890	1893	ROS	Chemical	MESH:D017382
37275754	1902	1914	inflammatory	Disease	MESH:D007249
37275754	1972	1984	P. australis	Species	29695;56345;256038;1396451;2506474
37275754	2009	2026	neuroinflammation	Disease	MESH:D000090862
37275754	2060	2072	P. australis	Species	29695;56345;256038;1396451;2506474
37275754	2103	2120	neuroinflammatory	Disease	MESH:D000090862
37275754	2125	2151	neurodegenerative diseases	Disease	MESH:D019636
37275754	Positive_Correlation	MESH:D008070	18126
37275754	Positive_Correlation	MESH:D008070	MESH:D015232
37275754	Positive_Correlation	MESH:D008070	MESH:D000090862
37275754	Positive_Correlation	MESH:D008070	16193
37275754	Positive_Correlation	MESH:D008070	21926
37275754	Positive_Correlation	MESH:D008070	MESH:D009569
37275754	Positive_Correlation	MESH:D008070	MESH:D017382
37275754	Positive_Correlation	MESH:D017382	MESH:D009410
37275754	Positive_Correlation	MESH:D008070	19225

